ArticleBMJ open respiratory research2025
Shared decision-making in the treatment of non-small cell lung cancer stage I-IV: perspectives from patients and clinicians.
Article in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Barriers and Facilitators to Shared Decision-Making in EGFRm Non-Small Cell Lung Cancer: Patient Perspectives.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDecision-making in non-small cell lung cancer (NSCLC) is complex and value-sensitive. A shared decision-making (SDM) approach is desirable to effectively weigh clinical considerations and patient preferences. However, implementing effective SDM remains challenging.
objectivesThis study explores the perspectives of patients with NSCLC and clinicians regarding SDM, identifying barriers and facilitators.
methodsTwo surveys were conducted: one with Dutch patients (n=116) and another with Dutch clinicians (n=143). The patient survey included demographics, treatment knowledge, information provision, decisional conflict scale and SDM. The clinician survey included demographics, patient information provision, treatment preferences (surgery vs radiation) using a 7-point Likert scale for five hypothetical cases, and SDM.
resultsPatients lacked knowledge about the advantages and disadvantages of different treatment options, especially regarding radiotherapy for early-stage NSCLC. 85% of patients and 70% of clinicians believed the final treatment decision should be made collaboratively. However, 69% of patients reported not being offered a choice of treatment options. Preferences varied significantly among specialties (p<0.01) in three out of five hypothetical cases. DISCUSSION: This study underscores the importance of SDM in NSCLC treatment, revealing gaps in patient knowledge, clinician SDM skills and information provision.
conclusionsSignificant discrepancies between patient and clinician perspectives, along with variation in treatment approaches, highlight the need for more personalised, patient-centred care, such as information portals and decision aids, in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.